New mRNA cancer vaccine targets lymph nodes for stronger immune response

Researchers at Tufts University have created a new mRNA vaccine for cancer that’s designed to carry its cargo to the lymph nodes rather than the liver. Tests in mice showed significant inhibition of the tumors, with the cancer disappearing completely i… Continue reading New mRNA cancer vaccine targets lymph nodes for stronger immune response

New mRNA cancer vaccine targets lymph nodes for stronger immune response

Researchers at Tufts University have created a new mRNA vaccine for cancer that’s designed to carry its cargo to the lymph nodes rather than the liver. Tests in mice showed significant inhibition of the tumors, with the cancer disappearing completely i… Continue reading New mRNA cancer vaccine targets lymph nodes for stronger immune response

UK approves BA.1 vaccines while US still waits for BA.5 boosters

Regulators in the United Kingdom have approved Moderna’s new Omicron-specific COVID-19 vaccine for an upcoming nation-wide autumn booster program. The approval makes the UK the first region in the world to formally move forward with an improved variant… Continue reading UK approves BA.1 vaccines while US still waits for BA.5 boosters

UK approves BA.1 vaccines while US still waits for BA.5 boosters

Regulators in the United Kingdom have approved Moderna’s new Omicron-specific COVID-19 vaccine for an upcoming nation-wide autumn booster program. The approval makes the UK the first region in the world to formally move forward with an improved variant… Continue reading UK approves BA.1 vaccines while US still waits for BA.5 boosters

Vaccine booster for all London children as polio found in more wastewater

A polio vaccine booster program has been announced in the United Kingdom targeting all London children under the age of 10. The program comes after more detections of poliovirus in London’s wastewater indicate the virus is spreading undetected througho… Continue reading Vaccine booster for all London children as polio found in more wastewater

New Lyme disease vaccine targets decades of anti-vax misinformation

A new Lyme disease vaccine is about to enter its final phase of human trialling. If all goes well it could be available by 2025, making it the first vaccine for Lyme disease to reach the market in nearly a quarter of a century.Continue ReadingCategory:… Continue reading New Lyme disease vaccine targets decades of anti-vax misinformation

Hydrogel casing keeps vaccines stable without refrigeration up to 150 °F

Most vaccines need to be refrigerated, which makes it difficult and expensive to get them to remote areas where they’re often needed most. Now, researchers at ETH Zurich have developed a new method for encapsulating vaccines in hydrogels so they can be… Continue reading Hydrogel casing keeps vaccines stable without refrigeration up to 150 °F

Antibody to prevent malaria infection aces first human trials

Promising results have been published from a Phase 1 human trial testing a novel antibody treatment designed to prevent malaria infection. Almost every volunteer was protected from infection after being deliberately exposed to malaria, indicating the u… Continue reading Antibody to prevent malaria infection aces first human trials

Polio detected in wastewater from New York county with only 60% vax rate

Following recent reports of the first polio case in the United States in almost a decade, the Centers for Disease Control and Prevention (CDC) reported the virus has been detected in wastewater samples as far back as June. The CDC indicates the polio d… Continue reading Polio detected in wastewater from New York county with only 60% vax rate

Oxford’s cheap, single-dose rabies vaccine passes Phase 1 human trials

A new single-shot rabies vaccine developed by researchers from the University of Oxford is showing promising results following a Phase 1 human clinical trial. Further clinical trials are now underway in the hopes the vaccine could help cut down the tho… Continue reading Oxford’s cheap, single-dose rabies vaccine passes Phase 1 human trials